Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Circulatory System Drugs (Find 39 items)

Circulatory System Drugs

Pitavastatin calcium

(147526-32-7)
Pitavastatin Calcium is a competitive inhibitor of the enzyme HMGCR. Alternate studies show that pitavastatin can suppress oxygen production in endothelial cells by inhibiting Nox. In addition, pitavastatin reduces the expression of eNOS mRNA while increasing the NO dependent response stimulated by acetylcholine and the calcium ionophore,A23187.

Product List

Request for quotation , get quotes from more suppliers.

Puerarin

(3681-99-0)
Puerarin is a natural isoflavone isolated from plants of the genus Pueraria used in traditional Chinese herbal medicine. It is biotransformed by intestinal bacteria to give the phytoestrogens daidzein and equol , resulting in antithrombotic, antiallergic, and other salutary effects. When given intraperitoneally, puerarin evokes diverse responses by modulating serotonin receptors. This compound also suppresses lipopolysaccharide-mediated activation of NF-κB in RAW 264.6 macrophages when given at

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Perindopril

(82834-16-0)
Labeled Perindopril, intended for use as an internal standard for the quantification of Perindopril by GC- or LC-mass spectrometry.

Product List

Request for quotation , get quotes from more suppliers.

Pazopanib

(444731-52-6)
Pazopanib Hydrochloride (GW786034, Votrient, Armala) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively. Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR-α/β, and c-Kit. Pazopanib is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM,

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Phentolamine methanesulfonate

(65-28-1)
An adrenergic blocking agent.An antihypertensive.Used for the treatment of pheochromocytoma.

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Pentoxifylline

(6493-05-6)
A metabolite of Pentifylline. Methylxanthine derivative that improves blood flow by decreasing blood viscosity. Phosphodiesterase inhibitor. Inhibits the synthesis of tumor necrosis factor α (TNF-α).

Product List

Request for quotation , get quotes from more suppliers.

Circulatory system drugs are about drugs that have the function of regulating the human circulatory system. The circulatory system is a system of body fluids (including blood, lymph and tissue fluids) and pipes through which circulation flows. Circulatory system drugs mainly include cardiovascular system drugs and diuretics. "Circulatory System Drugs" on ECHEMI covers lipid regulating drugs, angina pectoris drugs, calcium channel blockers, anti-congestive heart failure drugs, antihypertensive drugs, antiarrhythmics drugs, anti shock vasoactive drugs, ace inhibitor, peripheral vasodilators, heart failure treatments and drugs, Anti-atherosclerotic drugs, β-adrenergic receptor blockers and other circulatory system drugs, mainly supply raw materials for such drugs.

Frequently Asked Questions

What are circulatory system drugs used for?

Circulatory system drugs are medications designed to treat conditions affecting the heart and blood vessels. They are commonly used to manage hypertension (high blood pressure), heart failure, arrhythmias, angina, and to prevent blood clots. These drugs help regulate blood flow, reduce cardiac workload, and improve overall cardiovascular function, playing a critical role in both acute and chronic cardiovascular care.

What are the main types of circulatory system medications?

The main types of circulatory system drugs include:1. Antihypertensives (e.g., ACE inhibitors, beta-blockers, calcium channel blockers) for lowering blood pressure.2. Antiarrhythmics to stabilize irregular heart rhythms.3. Vasodilators that widen blood vessels to improve blood flow.4. Anticoagulants and antiplatelets (e.g., warfarin, aspirin) to prevent clot formation.5. Diuretics to reduce fluid buildup and lower blood pressure.Each class targets specific mechanisms within the cardiovascular system to achieve therapeutic effects.

How do I choose a reliable supplier for circulatory system APIs?

To choose a reliable supplier for circulatory system active pharmaceutical ingredients (APIs), consider the following criteria:1. Regulatory compliance—ensure the supplier holds certifications such as GMP, FDA approval, or EMA authorization.2. Quality assurance—verify robust testing protocols, documentation (e.g., COA, DMF), and traceability of raw materials.3. Manufacturing consistency—assess batch-to-batch reproducibility and scalability.4. Technical support and regulatory expertise to assist with global market requirements.Selecting a vetted, experienced API manufacturer minimizes risk and ensures drug safety and efficacy.

What quality standards apply to circulatory system drug intermediates?

Circulatory system drug intermediates must adhere to stringent quality standards to ensure final drug safety and performance. Key standards include compliance with ICH guidelines, GMP (Good Manufacturing Practice), and pharmacopeial specifications (e.g., USP, EP). Impurity profiles, residual solvents, and structural identity must be rigorously controlled. Reputable manufacturers conduct comprehensive analytical testing (HPLC, GC, NMR) and maintain full documentation for regulatory submissions.

Are there common side effects associated with circulatory system medications?

Yes, circulatory system drugs may cause side effects depending on the drug class. For example:- Beta-blockers can lead to fatigue, cold extremities, or bradycardia.- ACE inhibitors may cause a persistent dry cough or hyperkalemia.- Diuretics might result in electrolyte imbalances or dehydration.- Anticoagulants increase bleeding risk.Patients should always use these medications under medical supervision, and healthcare providers monitor for adverse reactions to optimize therapy safety and effectiveness.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.